Life ScienceCompany
FibroGen China Ownership
Who owns FibroGen China?
FibroGen China is owned by AstraZeneca. It was acquired on February 20, 2025.
FibroGen China Business Overview
Where is FibroGen China headquartered?
FibroGen China is headquartered in China.
What sector is FibroGen China in?
FibroGen China is a life science company.
Life Science M&A Summary in 2025
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.
Join Mergr to view all 62 acquisitions of life science companies in 2025, including 3 acquisitions by private equity firms, and 59 by strategics.